VENTYX BIOSCIENCES INC (VTYX) Forecast, Price Target & Analyst Ratings
NASDAQ:VTYX • US92332V1070
14 USD
+0.02 (+0.14%)
At close: Mar 3, 2026
13.99 USD
-0.01 (-0.07%)
After Hours: 3/3/2026, 8:00:02 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VENTYX BIOSCIENCES INC (VTYX).
Forecast Snapshot
Consensus Price Target
$13.64
-2.55% Downside
Next Earnings Forecast
Release DateMar 19, 2026
PeriodQ4 / 2025
EPS Estimate-$0.37
Revenue Estimate
ChartMill Buy Consensus
70.67%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$13.64
Upside
-2.55%
From current price of $14.00 to mean target of $13.64, Based on 15 analyst forecasts
Low
$9.09
Median
$14.28
High
$14.70
Price Target Revisions
1 Month
0.00%
3 Months
-8.55%
Price Target Summary
15 Wall Street analysts provided a forecast for the next 12 months for VTYX. The average price target is 13.64 USD. This implies a price decrease of -2.55% is expected in the next year compared to the current price of 14.
The average price target has been revised downward by 8.55% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
70.67%
VTYX was analyzed by 15 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about VTYX.
In the previous month the buy percentage consensus was at a similar level.
VTYX was analyzed by 15 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-08 | LifeSci Capital | Downgrade | Outperform -> Market Perform |
| 2026-01-08 | UBS | Downgrade | Buy -> Neutral |
| 2026-01-08 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2026-01-08 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2026-01-08 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2026-01-08 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2026-01-07 | UBS | Initiate | Buy |
| 2025-11-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-07 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-11-05 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2025-10-27 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-10-01 | Clear Street | Initiate | Buy |
| 2025-01-14 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-11-11 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-11-08 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-10-15 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-09-23 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-08-12 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-08-12 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-07-30 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-06-13 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-06-06 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-06-06 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-03-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-03-12 | Oppenheimer | Upgrade | Perform -> Outperform |
Next Earnings Forecast Details
Next Earnings Details
Release DateMar 19, 2026
PeriodQ4 / 2025
EPS Estimate-$0.37
Revenue Estimate
Revenue Q2QN/A
EPS Q2Q8.88%
Number of Analysts10
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.34%
Next Earnings Summary
VTYX is expected to report earnings on 3/19/2026. The consensus EPS estimate for the next earnings is -0.37 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 94.07% | N/A 72.84% | N/A 93.03% | N/A 87.82% | N/A 28.99% | |||||||
| EBITDA YoY % growth | -4.18M | -7.05M -68.66% | -67.12M -852.06% | -113.02M -68.38% | -207.536M -83.63% | -148.184M 28.60% | N/A 24.92% | N/A -9.82% | N/A -8.77% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -4.18M | -7.05M -68.66% | -67.15M -852.48% | -113.14M -68.49% | -207.694M -83.57% | -148.45M 28.52% | N/A 19.78% | N/A -34.69% | N/A -8.35% | N/A 39.84% | N/A 16.67% | N/A 116.67% | N/A 2,056.81% | N/A 139.41% | N/A 37.10% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -2.05 73.27% | -3.30 -60.98% | -1.98 40.00% | N/A 25.50% | N/A -17.89% | N/A -10.36% | N/A 46.68% | N/A 22.26% | N/A 84.62% | N/A 1,494.42% | N/A 158.77% | N/A 32.91% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.37 8.88% | -0.42 -7.23% | -0.44 -16.31% | -0.47 -48.22% | -0.46 -23.65% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -32.592M -0.54% | -34.023M -13.04% | -36.051M -22.90% | -38.87M -56.27% | -41.272M -26.63% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
1.01%
EPS Next 5 Year
9.83%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
5.59%
EBIT Next 5 Year
N/A
VENTYX BIOSCIENCES INC / VTYX Forecast FAQ
What is the average price target for VENTYX BIOSCIENCES INC (VTYX) stock?
15 analysts have analysed VTYX and the average price target is 13.64 USD. This implies a price decrease of -2.55% is expected in the next year compared to the current price of 14.
What is the next earnings date for VTYX stock?
VENTYX BIOSCIENCES INC (VTYX) will report earnings on 2026-03-19, after the market close.
What are the consensus estimates for VENTYX BIOSCIENCES INC (VTYX) next earnings?
The consensus EPS estimate for the next earnings of VENTYX BIOSCIENCES INC (VTYX) is -0.37 USD and the consensus revenue estimate is 0 USD.